Abstract
The present invention relates to methods for treating multiple sclerosis (MS) in a patient which in some cases involves subcutaneously administering an anti-CD20 antibody into the patient at a dose of about 920 mg. Compositions, formulations and articles of manufacture with instructions for such use are also included.
Full Text
What is claimed is:
The present invention relates to methods for treating multiple sclerosis (MS) in a patient which in some cases involves subcutaneously administering an anti-CD20 antibody into the patient at a dose of about 920 mg. Compositions, formulations and articles of manufacture with instructions for such use are also included.
Timeline
Filed
05/04/2026Published
08/27/2026Granted
Not AvailableIPC Codes(6)
C07K 16/28:against receptors, cell surface antigens or cell surface determinants
A61K 47/12:Carboxylic acids; Salts or anhydrides thereof
A61K 47/20:containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids